New insights in photodynamic inactivation of Leishmania amazonensis: A focus on lipidomics and resistance.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2023
2023
Historique:
received:
09
02
2023
accepted:
19
07
2023
medline:
18
9
2023
pubmed:
15
9
2023
entrez:
15
9
2023
Statut:
epublish
Résumé
The emergence of drug resistance in cutaneous leishmaniasis (CL) has become a major problem over the past decades. The spread of resistant phenotypes has been attributed to the wide misuse of current antileishmanial chemotherapy, which is a serious threat to global health. Photodynamic therapy (PDT) has been shown to be effective against a wide spectrum of drug-resistant pathogens. Due to its multi-target approach and immediate effects, it may be an attractive strategy for treatment of drug-resistant Leishmania species. In this study, we sought to evaluate the activity of PDT in vitro using the photosensitizer 1,9-dimethyl methylene blue (DMMB), against promastigotes of two Leishmania amazonensis strains: the wild-type (WT) and a lab induced miltefosine-resistant (MFR) strain. The underlying mechanisms of DMMB-PDT action upon the parasites was focused on the changes in the lipid metabolism of both strains, which was conducted by a quantitative lipidomics analysis. We also assessed the production of ROS, mitochondrial labeling and lipid droplets accumulation after DMMB-PDT. Our results show that DMMB-PDT produced high levels of ROS, promoting mitochondrial membrane depolarization due to the loss of membrane potential. In addition, both untreated strains revealed some differences in the lipid content, in which MFR parasites showed increased levels of phosphatidylcholine, hence suggesting this could also be related to their mechanism of resistance to miltefosine. Moreover, the oxidative stress and consequent lipid peroxidation led to significant phospholipid alterations, thereby resulting in cellular dysfunction and parasite death. Thus, our results demonstrated that DMMB-mediated PDT is effective to kill L. amazonensis MFR strain and should be further studied as a potential strategy to overcome antileishmanial drug resistance.
Identifiants
pubmed: 37713373
doi: 10.1371/journal.pone.0289492
pii: PONE-D-23-03795
pmc: PMC10503701
doi:
Substances chimiques
dimethylmethylene blue
0
miltefosine
53EY29W7EC
Reactive Oxygen Species
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0289492Informations de copyright
Copyright: © 2023 Cabral et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Photochem Photobiol B. 2020 Jul;208:111893
pubmed: 32446039
Can J Biochem Physiol. 1959 Aug;37(8):911-7
pubmed: 13671378
Mol Microbiol. 2016 Mar;99(6):1134-48
pubmed: 26713880
Mol Microbiol. 2006 Jul;61(1):89-105
pubmed: 16824097
Curr Biol. 2013 Aug 5;23(15):1489-96
pubmed: 23871243
Trends Biochem Sci. 1997 Jul;22(7):267-72
pubmed: 9255069
Nat Rev Microbiol. 2011 Jul 11;9(8):604-15
pubmed: 21747391
Aust N Z J Med. 1995 Dec;25(6):768-76
pubmed: 8770352
Mol Biosyst. 2017 Oct 24;13(11):2401-2406
pubmed: 28960008
Phytomedicine. 2019 Aug;61:152894
pubmed: 31054439
PLoS Pathog. 2012;8(5):e1002695
pubmed: 22615560
Antimicrob Agents Chemother. 2005 Jul;49(7):2677-86
pubmed: 15980336
Photodiagnosis Photodyn Ther. 2017 Jun;18:325-330
pubmed: 28457848
Mol Microbiol. 2009 May;72(4):1068-79
pubmed: 19400804
Curr Opin Microbiol. 2016 Oct;33:67-73
pubmed: 27421070
Mol Biochem Parasitol. 2003 Feb;126(2):165-72
pubmed: 12615315
Lancet Infect Dis. 2007 Sep;7(9):581-96
pubmed: 17714672
Photodiagnosis Photodyn Ther. 2004 Dec;1(4):279-93
pubmed: 25048432
Biochim Biophys Acta Gen Subj. 2021 Jul;1865(7):129897
pubmed: 33811942
Chem Phys Lipids. 2009 Jan;157(1):1-11
pubmed: 18977338
Nat Rev Mol Cell Biol. 2019 Mar;20(3):137-155
pubmed: 30523332
Int J Parasitol Drugs Drug Resist. 2013 Dec 05;4(1):20-7
pubmed: 24596665
Physiol Rev. 2014 Jul;94(3):909-50
pubmed: 24987008
PLoS Negl Trop Dis. 2017 Dec 14;11(12):e0006052
pubmed: 29240765
Front Cell Dev Biol. 2017 Sep 29;5:90
pubmed: 29034233
Comp Immunol Microbiol Infect Dis. 2004 Sep;27(5):305-18
pubmed: 15225981
Traffic. 2015 Jan;16(1):1-18
pubmed: 25243850
Sci Rep. 2019 May 20;9(1):7602
pubmed: 31110206
BMJ Glob Health. 2018 May 3;3(3):e000709
pubmed: 29736277
Antimicrob Agents Chemother. 2007 Apr;51(4):1425-30
pubmed: 17242145
Trends Parasitol. 2017 Mar;33(3):162-174
pubmed: 27993477
Parasitology. 2010 Aug;137(9):1357-92
pubmed: 20602846
PLoS Negl Trop Dis. 2019 Feb 25;13(2):e0007092
pubmed: 30802261
Microorganisms. 2021 Apr 09;9(4):
pubmed: 33918954
Front Cell Infect Microbiol. 2021 Apr 30;11:653670
pubmed: 33996631
Clin Microbiol Rev. 2006 Jan;19(1):111-26
pubmed: 16418526
Autophagy. 2019 Feb;15(2):259-279
pubmed: 30176156
J Photochem Photobiol B. 2021 Aug;221:112236
pubmed: 34090038
Photochem Photobiol. 2020 May;96(3):604-610
pubmed: 31792979
Clin Exp Dermatol. 2004 Sep;29(5):464-7
pubmed: 15347324
Biochim Biophys Acta. 1999 Oct 8;1455(2-3):327-40
pubmed: 10571022
IUBMB Life. 2010 Jun;62(6):414-28
pubmed: 20503434
FASEB J. 2015 Oct;29(10):4201-13
pubmed: 26116701
Mol Biochem Parasitol. 2010 Apr;170(2):55-64
pubmed: 20026359
Photochem Photobiol. 2014 Jul-Aug;90(4):801-13
pubmed: 24571440
Adv Parasitol. 2006;61:223-74
pubmed: 16735166
Lancet. 2018 Sep 15;392(10151):951-970
pubmed: 30126638
Yale J Biol Med. 2019 Sep 20;92(3):435-452
pubmed: 31543707
PLoS Genet. 2019 Dec 23;15(12):e1008548
pubmed: 31869331
PLoS Negl Trop Dis. 2016 Jul 14;10(7):e0004720
pubmed: 27416021
Front Cell Dev Biol. 2020 Feb 07;8:63
pubmed: 32117988
PLoS Negl Trop Dis. 2016 Dec 2;10(12):e0005171
pubmed: 27911896